Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)


Condition: Cholangiocarcinoma, Gall Bladder Carcinoma

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT02170090

Sponsor: Universitätsklinikum Hamburg-Eppendorf

Phase: Phase 3

Eligibility:

  • Age: minimum 18 Years maximum N/A
  • Gender: All

Eligibility Criteria:

  • for patients to be included in the radiotherapy substudy:
  • R1 (microscopic positive margin)
  • no previous radiotherapy to abdomen

View trial on ClinicalTrials.gov